Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 500 participants.
Also called NCT02828683
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT02828683
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil, Italy, North Macedonia, Serbia, Spain
- Registry status
- Completed
Technical summary
Registry record NCT02828683. Randomized; single masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2016-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study
- Acronym
- MASTER
- Condition
- Acute ST Segment Elevation Myocardial Infarction
- Intervention (Device)
- PCI (percutaneous coronary intervention) in patients with ST-elevation myocardial infarction
- Intervention (Device)
- PCI in patients with ST-elevation myocardial infarction
- Lead sponsor
- Terumo Europe N.V.
Record details
- Record id
cardio:ct-nct02828683- Content hash
ce27f31f7c3f831d43509c3780dd717a098db5fd74bd39ec7b7c180daf2c11a5